Vidcast: https://www.instagram.com/p/CtVkao6LrCL/

Newly approved is a fully automatic Bionic Pancreas developed by the Beta Bionics company for use by insulin-dependent Type 1 diabetics 6 years and older.  Unlike already available insulin pumps, the iLet Bionic Pancreas control software requires only the input of a patient’s weight and an estimate of carbohydrate meal contents as low, medium, or high.  It then uses continuous blood glucose measurements to control the delivery of short- and long-acting insulin.  The system learns the optimal patterns, and a previously published Harvard Mass. General Hospital study revealed that the system delivers greater reductions of glycogen hemoglobin or HbA1c than current insulin delivery systems.

https://jamanetwork.com/journals/jama/fullarticle/2805745

https://www.nejm.org/doi/10.1056/NEJMoa2205225

#diabetes #insulin #bionicpancreas #insulinpump #hbA1C